To provide further evidence supporting the therapeutic potential of this class of natriuretic hormones, in this work we verified if also BNP and CNP were able to positively affect the Wnt/β-cat signaling and to possess neuroprotective abilities in in vitro models of PD, similarly to what previously demonstrated for ANP [55]. The gene discussed is CNP; the disease is Parkinson disease.